脳深部刺激装置市場：製品タイプ別、用途別、エンドユーザー別、地域別

脳深部刺激装置の世界市場は、2025年には16億6,000万米ドルと推定され、2032年には33億8,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は10.7%で成長すると予測されています。

図.脳深部刺激装置市場シェア（%）、2025年地域別

世界の脳深部刺激装置市場は、過去数年間で大きな成長を遂げています。脳深部刺激療法（DBS）は、脳ペースメーカーと呼ばれる医療機器を埋め込む神経外科手術であり、神経疾患や精神疾患を治療するために、埋め込まれた電極を通して脳の特定のターゲットに電気インパルスを送ります。脳深部刺激は、パーキンソン病、ジストニア、本態性振戦などの症状を軽減するのに役立ちます。効果やバッテリー寿命が改善された充電式デバイスの開発など、神経学的デバイスの技術的進歩がDBS手技の普及に拍車をかけています。さらに、神経変性疾患にかかりやすい老年人口が世界的に増加していることも、脳深部刺激装置の需要増に寄与しています。しかし、機器に関連する高額な費用と手技の複雑さが、予測期間中の市場成長をある程度抑制する可能性があります。

市場力学：

神経疾患の有病率の上昇、老年人口の増加、高度な治療オプションに対する意識の高まり、技術開発などの主な要因が、世界の脳深部刺激装置市場の成長を促進しています。パーキンソン財団によると、毎年約6万人のアメリカ人がパーキンソン病と診断されています。同様に、アルツハイマー病や関連する認知症と診断される人の数も、今後数年で劇的に増加すると予想されています。しかし、市場の成長はいくつかの要因によって抑制される可能性があります。脳深部刺激療法やデバイスに関連する高額な費用、限られた保険償還範囲、複雑なDBS手術を行う熟練した医療専門家の不足などは、市場が直面する主な課題の一部です。さらに、デバイスの誤作動に関する問題や、規制当局による新しいデバイスの承認プロセスに時間がかかることも、市場拡大の妨げとなっています。その反面、リアルタイムのワイヤレスプログラミングを備えた改良型デバイスの開発研究が進行中であり、患者中心のケアに重点を置く傾向が強まっているため、今後数年間は市場プレイヤーにとって有利な機会がもたらされます。

この調査の主な特徴

この調査レポートは、世界の脳深部刺激装置市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の脳深部刺激装置市場の主要企業プロファイルを掲載しています。

本調査の対象となる主要企業には、Abbott、Medtronic、Boston Scientific Corporation、Neuropace Inc.、LivaNova Plc、Renishaw Plc、Aleva Neurotherapeutics S.A.、Beijing Pinchi Medical Equipment Co.Ltd、Nexstim、St. Jude Medical（現在はAbbott傘下）、Cyberonics（現在はLivaNova傘下）、EBR Systems、IntraPace、Nevro Corp、Stimwave Technologies.

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の脳深部刺激装置市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。

利害関係者は、世界の脳深部刺激装置市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向の分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の脳深部刺激装置市場、製品タイプ別、2020年～2032年

• シングルチャネルDBSデバイス
• デュアルチャネルDBSデバイス

第5章 世界の脳深部刺激装置市場、用途別、2020年～2032年

• てんかん
• 疼痛管理
• 本態性振戦
• 強迫性障害（OCD）
• パーキンソン病
• うつ
• ジストニア
• その他

第6章 世界の脳深部刺激装置市場、エンドユーザー別、2020年～2032年

• 病院
• 神経科クリニック
• 外来手術センター
• 研究センター
• その他

第7章 世界の脳深部刺激装置市場、地域別、2020年～2032年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• Abbott
• Medtronic
• Boston Scientific Corporation
• Neuropace Inc.
• LivaNova Plc
• Renishaw Plc
• Aleva Neurotherapeutics S.A.
• Beijing Pinchi Medical Equipment Co. Ltd
• Nexstim
• Jude Medical（now part of Abbott）
• Cyberonics（now part of LivaNova）
• EBR Systems
• IntraPace
• Nevro Corp
• Stimwave Technologies

第9章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫した機会マップ

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global Deep Brain Stimulation Devices Market is estimated to be valued at US$ 1.66 Bn in 2025 and is expected to reach US$ 3.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2032.

Figure. Deep Brain Stimulation Devices Market Share (%), By Region 2025

The global deep brain stimulation devices market has been witnessing significant growth over the past few years. Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a brain pacemaker which sends electrical impulses, through implanted electrodes, to specific targets in the brain for treating neurological and psychiatric disorders. Deep brain stimulation helps reduce symptoms of diseases like Parkinson's disease, dystonia, essential tremor among others. Technological advancements in neurological devices like the development of rechargeable devices with improved efficacy and battery life have been fueling the uptake of DBS procedures. Moreover, the growing geriatric population worldwide who are more prone to neurodegenerative disorders has been contributing to the rising demand for deep brain stimulation devices. However, high costs associated with the devices and complexity of procedures might restrain the market growth to some extent during the forecast period.

Market Dynamics:

The key factors such as rising prevalence of neurological disorders, increasing geriatric population, growing awareness about advanced treatment options, and technological developments are fueling the growth of the global deep brain stimulation devices market. According to the Parkinson's Foundation, around 60,000 Americans are diagnosed with Parkinson's disease each year. Similarly, the number of people diagnosed with Alzheimer's disease and related dementias is expected to rise dramatically in coming years. However, the market growth can be restrained by some factors. High costs associated with deep brain stimulation procedures and devices, limited reimbursement coverage and lack of skilled healthcare professionals to perform complex DBS surgeries are some of the major challenges faced by the market. Moreover, issues related to device malfunctions and lengthy approval processes for new devices by regulatory authorities also hinder the market progression. On the flip side, ongoing research for development of improved devices with real-time wireless programming and increased focus on patient-centered care present lucrative opportunities for market players in the coming years.

Key features of the study:

This report provides in-depth analysis of the global deep brain stimulation devices market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global deep brain stimulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, Medtronic, Boston Scientific Corporation, Neuropace Inc., LivaNova Plc, Renishaw Plc, Aleva Neurotherapeutics S.A., Beijing Pinchi Medical Equipment Co. Ltd, Nexstim, St. Jude Medical (now part of Abbott), Cyberonics (now part of LivaNova), EBR Systems, IntraPace, Nevro Corp, Stimwave Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global deep brain stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global deep brain stimulation devices market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Single-channel DBS Devices
  • Dual-channel DBS Devices
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Epilepsy
  • Pain Management
  • Essential Tremor
  • Obsessive Compulsive Disorder (OCD)
  • Parkinson's Disease
  • Depression
  • Dystonia
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Research Centers
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Neuropace Inc.
  • LivaNova Plc
  • Renishaw Plc
  • Aleva Neurotherapeutics S.A.
  • Beijing Pinchi Medical Equipment Co. Ltd
  • Nexstim
  • Jude Medical (now part of Abbott)
  • Cyberonics (now part of LivaNova)
  • EBR Systems
  • IntraPace
  • Nevro Corp
  • Stimwave Technologies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Deep Brain Stimulation Devices Market, By Product Type
  • Global Deep Brain Stimulation Devices Market, By Application
  • Global Deep Brain Stimulation Devices Market, By End User
  • Global Deep Brain Stimulation Devices Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Deep Brain Stimulation Devices Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single-channel DBS Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dual-channel DBS Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Deep Brain Stimulation Devices Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Epilepsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Essential Tremor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Obsessive Compulsive Disorder (OCD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parkinson's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dystonia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Deep Brain Stimulation Devices Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Deep Brain Stimulation Devices Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Neuropace Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LivaNova Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Renishaw Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aleva Neurotherapeutics S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beijing Pinchi Medical Equipment Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nexstim
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jude Medical (now part of Abbott)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyberonics (now part of LivaNova)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EBR Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IntraPace
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nevro Corp
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stimwave Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us